Quarterly Result13 May 2026, 08:11 pm
Metropolis Healthcare Q4FY26: EBITDA up 71% YoY, PAT rises 75%
AI Summary
Metropolis Healthcare Ltd reported a strong Q4FY26 performance with a 23% YoY increase in revenue to ₹425 Cr. EBITDA rose by 71% YoY to ₹108 Cr, and PAT increased by 75% YoY to ₹51 Cr. Patient volumes grew 11% YoY, and test volumes increased 14% YoY. The Board has approved a dividend of ₹1 per share. B2C revenues grew 20% YoY, while B2B revenues increased 28% YoY. TruHealth and Specialty portfolios grew 24% YoY and 31% YoY, respectively.
Key Highlights
- Q4FY26 revenue increased by 23% YoY to ₹425 Cr.
- EBITDA for Q4FY26 grew 71% YoY to ₹108 Cr.
- PAT for Q4FY26 increased 75% YoY to ₹51 Cr.
- The Board approved a dividend of ₹1 per share.
- Patient volumes grew 11% YoY, and test volumes increased 14% YoY.